LIFEVANTAGE CORP Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LIFEVANTAGE CORP shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2016-12-31 was $2.00K, a 99.61% decline year-over-year.
- LIFEVANTAGE CORP shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2016-09-30 was $5.00K.
- LIFEVANTAGE CORP shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2016-03-31 was -$21.00K, a 105.54% decline year-over-year.
- LIFEVANTAGE CORP shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2015-12-31 was $508.00K, a 215.53% increase year-over-year.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2016-12-31 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-08 | |
| 2016-09-30 | $5.00K 10-Q · filed 2016-12-12 | |
| 2016-03-31 | -$21.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2016-07-19 | |
| 2015-12-31 | $508.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-09 | |
| 2015-09-30 | -$19.00K 10-Q · filed 2015-11-04 | |
| 2015-03-31 | $379.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-06 | |
| 2014-12-31 | $161.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-04 | |
| 2014-09-30 | $35.00K 10-Q · filed 2014-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |